SGD 0.29
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 155.67 Million SGD | -5.74% |
2022 | 165.16 Million SGD | -4.49% |
2021 | 172.93 Million SGD | 15.4% |
2020 | 149.85 Million SGD | -17.95% |
2019 | 182.64 Million SGD | 78.25% |
2018 | 102.46 Million SGD | -3.48% |
2017 | 106.16 Million SGD | -1.5% |
2016 | 107.77 Million SGD | 0.1% |
2015 | 107.67 Million SGD | 93.6% |
2014 | 55.61 Million SGD | 165.85% |
2013 | 20.92 Million SGD | 2.72% |
2012 | 20.36 Million SGD | 120.34% |
2011 | 9.24 Million SGD | 63.74% |
2010 | 5.64 Million SGD | 13.65% |
2009 | 4.96 Million SGD | 34.97% |
2008 | 3.68 Million SGD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 145.04 Million SGD | 0.0% |
2024 Q1 | 145.04 Million SGD | -6.83% |
2023 Q3 | - SGD | -100.0% |
2023 Q2 | 158.55 Million SGD | 0.0% |
2023 FY | 155.67 Million SGD | -5.74% |
2023 Q1 | - SGD | -100.0% |
2023 Q4 | 155.67 Million SGD | 0.0% |
2022 Q2 | 161.92 Million SGD | -2.14% |
2022 FY | 165.16 Million SGD | -4.49% |
2022 Q4 | 165.16 Million SGD | 1.79% |
2022 Q1 | 165.45 Million SGD | -4.32% |
2022 Q3 | 162.26 Million SGD | 0.21% |
2021 Q3 | 165.26 Million SGD | 3.76% |
2021 Q2 | 159.27 Million SGD | -2.74% |
2021 Q1 | 163.77 Million SGD | 9.29% |
2021 FY | 172.93 Million SGD | 15.4% |
2021 Q4 | 172.93 Million SGD | 4.64% |
2020 FY | 149.85 Million SGD | -17.95% |
2020 Q4 | 149.85 Million SGD | 0.0% |
2020 Q2 | 147.57 Million SGD | 0.0% |
2019 Q4 | 182.64 Million SGD | 33.02% |
2019 FY | 182.64 Million SGD | 78.25% |
2019 Q3 | 137.31 Million SGD | -0.43% |
2019 Q1 | 119.15 Million SGD | 16.29% |
2019 Q2 | 137.9 Million SGD | 15.73% |
2018 FY | 102.46 Million SGD | -3.48% |
2018 Q3 | 100.92 Million SGD | -3.09% |
2018 Q2 | 104.14 Million SGD | -1.08% |
2018 Q4 | 102.46 Million SGD | 1.52% |
2018 Q1 | 105.28 Million SGD | -0.83% |
2017 Q2 | 101.13 Million SGD | -2.93% |
2017 Q1 | 104.18 Million SGD | -3.33% |
2017 FY | 106.16 Million SGD | -1.5% |
2017 Q3 | 101.33 Million SGD | 0.2% |
2017 Q4 | 106.16 Million SGD | 4.76% |
2016 Q2 | 115.26 Million SGD | -2.25% |
2016 Q4 | 107.77 Million SGD | 4.12% |
2016 Q1 | 117.92 Million SGD | 9.52% |
2016 FY | 107.77 Million SGD | 0.1% |
2016 Q3 | 103.51 Million SGD | -10.19% |
2015 FY | 107.67 Million SGD | 93.6% |
2015 Q4 | 107.67 Million SGD | -4.74% |
2015 Q3 | 113.03 Million SGD | 3.54% |
2015 Q2 | 109.16 Million SGD | 2.03% |
2015 Q1 | 106.99 Million SGD | 92.39% |
2014 Q1 | 19.24 Million SGD | -8.0% |
2014 Q4 | 55.61 Million SGD | -32.59% |
2014 Q3 | 82.5 Million SGD | 165.69% |
2014 FY | 55.61 Million SGD | 165.85% |
2014 Q2 | 31.05 Million SGD | 61.35% |
2013 FY | 20.92 Million SGD | 2.72% |
2013 Q1 | 16.63 Million SGD | -18.33% |
2013 Q3 | 25.91 Million SGD | 25.73% |
2013 Q4 | 20.92 Million SGD | -19.27% |
2013 Q2 | 20.6 Million SGD | 23.9% |
2012 Q1 | 7.24 Million SGD | -21.61% |
2012 Q2 | 12.78 Million SGD | 76.43% |
2012 FY | 20.36 Million SGD | 120.34% |
2012 Q3 | 16.39 Million SGD | 28.25% |
2012 Q4 | 20.36 Million SGD | 24.22% |
2011 Q3 | 7.4 Million SGD | 4.42% |
2011 FY | 9.24 Million SGD | 63.74% |
2011 Q2 | 7.08 Million SGD | 1.72% |
2011 Q1 | 6.96 Million SGD | 23.45% |
2011 Q4 | 9.24 Million SGD | 24.87% |
2010 Q2 | 3.77 Million SGD | 0.0% |
2010 FY | 5.64 Million SGD | 13.65% |
2010 Q4 | 5.64 Million SGD | 0.0% |
2009 Q4 | 4.96 Million SGD | 0.0% |
2009 FY | 4.96 Million SGD | 34.97% |
2008 FY | 3.68 Million SGD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Raffles Medical Group Ltd | 484.37 Million SGD | 67.86% |